Mark L Baum has bought stock on 3 days since Nov 2018
CEO at Harrow, Inc., and 1 other company
SEC CIK 0001274282 · Filings on SEC.gov ↗
Mark L Baum's record
3 months after each buy, from the first price a copier could get.
2 buys have 3 months of prices so far. A record shows here at 3.
Companies
Every filing
3 filings since Nov 2018, newest first
About Mark L Baum
Mark L. Baum is the founder, Chairman of the Board, and Chief Executive Officer of Harrow, Inc. (NASDAQ: HROW), a role he has held since 2012.( Under his leadership, Harrow has grown into an ophthalmic pharmaceutical company focused on developing and commercializing eyecare products. Baum also serves as a founder and former board member of Eton Pharmaceuticals and Surface Ophthalmics, and is the current Chairman of Melt Pharmaceuticals.(
Before founding Harrow, Baum founded TBLF, LLC, a private investment fund manager through which he made more than 200 investments in over 40 private and public companies. He also founded YesRx in 1999, an HIV-focused pharmacy business.( Baum earned a cum laude degree from the University of Texas at Arlington and received his law degree from the California Western School of Law in 1997.(
Written by Perplexity from public sources.
Filings come from SEC EDGAR. Not investment advice.